Global Anatomic Pathology Market: Snapshot
The global anatomic pathology market is treading growth on the back of extensive use of anatomic pathology for identifying and managing tumors that are growing at an alarming rate. According to statistics of GLOBOCAN, around 15.2 million cancer cases were reported globally in 2015, and this number is estimated to reach 19 million by 2025.
Changing lifestyle and inadvertent exposure to radiation that have resulted in prevalence of chronic diseases to be at an all-time high is also stoking growth of the anatomic pathology market. As per the World Health Report, chronic diseases are anticipated to be responsible for more than 70% deaths globally by 2020.
According to a report by Transparency Market Research (TMR), the global anatomic pathology market is likely to expand at a CAGR of 6.5% for the forecast period between 2017 and 2025, for the market to attract a revenue of US$30,314..5 mn by 2025-end. The global anatomic pathology market stood at US$17,318.0 mn in 2016.
Instruments Products & Services Segment to Emerge Attractive in Forthcoming Years
The global anatomic pathology market has been studied on the basis of products & services, application, end-user, and geography in this report. Based on products & services, the segments that could divide this market include instruments, consumables, and services. The instruments segment has been further divided into tissue processor, slide strainer, microtomes, and others.
Amongst all, the services segment stood as the leading contributor holding approximately 45.9% market share in 2016. The growth of this segment is mainly due to rising prevalence of critical illnesses that require immediate medical attention. However, the instruments segment is likely to expand at a significant 7.2% CAGR for the forecast period between 2017 and 2025, due to technological advancements that will lead to the production of innovative instruments.
In terms of application, the segments that divide the global anatomic pathology market include disease diagnosis, drug discovery, and others. Of them, the segment of disease diagnosis held the leading share of more than 47% in the overall market in 2016. This is mainly due to increasing use of technologically advanced devices for disease diagnosis. However, drug discovery is anticipated to exhibit robust growth over the forecast period mainly due to increasing expenditure by government and non-government organizations on R&D for the introduction of novel and high efficacy drugs.
The segments of this market depending upon end-user are diagnostic centers, hospitals, and research organization. Amongst all, diagnostic centers have remained the most preferable owing to their low cost attribute for diagnosis and treatment. Further, the segment of diagnostic centers is anticipated to register a strong growth rate over the forecast period owing to extensive use of anatomic assays, availability of novel molecular testing instruments, and availability of anatomic pathology testing kits to detect various types of cancers at low cost.
Early Adoption of Technology Makes North America Leader
Geographically, the report studies the global anatomic pathology market across North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. North America currently holds command in the overall market; the region held the leading more than 40% market share in 2016. The dominance of this region is attributed to growing aging population and rising prevalence of chronic diseases. Moreover, in countries such as the U.S., factors such as a highly structured healthcare industry, implementation of Affordable Care Act, and rise in public awareness leading vendors to develop innovative products are acting in favor of the growth of North America anatomic pathology market.
Key participants operating in the global anatomic pathology market covered in this report include Abbott Laboratories, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Sakura Finetek USA Inc., Danaher Corporation, Quest Diagnostics Incorporated, Agilent Technologies Inc., and NeoGenomics Laboratories among others.
Global Anatomic Pathology Market: Overview
This report on anatomic pathology market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of anatomic pathology as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global anatomic pathology market with respect to the leading market segments based on major products & services segment, application, end-user and geographies.
Global Anatomic Pathology Market: Market Segmentation
Based on the product & services, the anatomic pathology market has been segmented into: instruments (tissue processors, slide strainer, microtomes and others), consumables (reagents and antibodies) and services (histopathology and cytopathology). Each of the market segments have been extensively analyzed based on the market related factors such as increasing rate of chronic diseases incidences worldwide, technological advancement, and growing number of use of anatomic pathology in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Anatomic Pathology Market: Scope of Study
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the anatomic pathology market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global anatomic pathology market.
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global anatomic pathology market.
Global Anatomic Pathology Market: Regional Landscape and Competitive Dynamics
Geographically, anatomic pathology market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, value chain analysis, and heat map analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global Anatomic Pathology market.
The report also profiles key players operating in the Anatomic Pathology market which are Abbott Laboratories, Agilent Technologies, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Inc., Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., Thermo Fisher Scientific, Inc. and other prominent players.
The global anatomic pathology market is segmented as follows:
Anatomic Pathology Market, by Product & Services
- Tissue Processor
- Slide Strainer
Anatomic Pathology Market, by Application
- Disease Diagnosis
- Drug Discovery
Anatomic Pathology Market, by End-user
- Diagnostic Centers
- Research Organization
Anatomic Pathology Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa